AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,069,317 | +34.7% | 15,300 | +38.5% | 0.00% | 0.0% |
| Q2 2023 | $794,053 | +29.4% | 11,050 | +11.1% | 0.00% | +100.0% |
| Q1 2023 | $613,716 | -15.4% | 9,950 | +5.9% | 0.00% | -50.0% |
| Q4 2022 | $725,022 | +87.8% | 9,400 | +8.7% | 0.00% | +100.0% |
| Q3 2022 | $386,000 | -11.1% | 8,650 | -23.6% | 0.00% | 0.0% |
| Q2 2022 | $434,000 | -7.5% | 11,320 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $469,000 | +9.6% | 11,320 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $428,000 | -45.3% | 11,320 | -2.4% | 0.00% | -50.0% |
| Q2 2021 | $782,000 | -23.6% | 11,597 | -35.9% | 0.00% | 0.0% |
| Q1 2021 | $1,024,000 | -30.5% | 18,082 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $1,473,000 | +14.4% | 18,082 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,288,000 | +115.7% | 18,082 | +149.2% | 0.00% | +50.0% |
| Q2 2020 | $597,000 | +39.8% | 7,256 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $427,000 | – | 7,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |